Durvalumab Injection for intravenous use 500 mg vial solution for infusion

Who we are

  • October 31, 2023
    Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial